18 September 2018

SALT Announces Largest Expansion to Date; Now in 80 Percent of the U.S., Totaling 10 International Territories

SALT, the world's premiere provider of cryptocurrency collateralized Blockchain-Backed Loans™, today announces its most significant expansion to date, opening operations in 15 additional U.S. jurisdictions including New Jersey, Massachusetts, Washington and Texas, as well as an additional 7 territories including Brazil, Hong Kong, Switzerland, Bermuda, Vietnam, Puerto Rico and the United Arab Emirates. This rapid expansion of services comes on the heels of SALT's 20-state expansion in August as the company approaches its goal of being fully operational in all 50 states.
As SALT continues its global expansion, its competitive offerings— including flexible loan terms, no origination fee, no prepayment fee, and no servicing fee or closing costs— enable the company to maintain its position as market leader "The number of cryptocurrency holders has already increased by more than 70 percent worldwide during the past year, which points to the potential of a dramatic increase in loan demand," said Bill Sinclair, Interim President and CEO of SALT. "Given SALT is also one of the few companies that actually lends in fiat currency, we're in a unique position to democratize loan access by providing a multi-faceted loan service to businesses and consumers across the world."

This expansion and greater flexibility for borrowers supports SALT's mission to not only increase loan access but to also grant its customers maximum utility of their assets. With more than 60 percent of cryptocurrency trading in international currencies, SALT seeks to continue increasing international exposure and providing its services to crypto holders across the globe. "Overall, it's about providing more liquidity to the crypto-market," Sinclair continued. "This is yet another leap forward in allowing both the banked and unbanked to gain access to traditional financial institutions through their blockchain assets."

No comments: